The website has been completed and opened. | |
---|---|
April 25, 2022 | |
The website has been completed
and opened on April 25th. We have redesigned the style of the website,
especially with user-friendly illustrations to introduce our technologies
and pipelines. We hope it presents a clearer insight into our work and aspirations.
We will continue to update and upgrade our
homepage with the latest information.
|
|
Prev | Incurix's MYC inhibitor emerges as first-line therapy option for lung cancer patients: Presented at AACR |
Next | Incurix signs agreement with AIGEN Sciences for joint development on AI-based Transcription Factor inhibitor |